EP3097120
Mótefni úr mönnum við PD-L1
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
23.1.2015EP published:
23.1.2019EP application number:
15703380.4
EP translation filed:
14.2.2019Grant published:
15.4.2019EPO information:
European Patent Register
Max expiry date:
22.1.2035Expiry date:
22.1.2027Next due date:
31.1.2027
Title:
HUMAN ANTIBODIES TO PD-L1
Timeline
Today
23.1.2015EP application
23.1.2019EP Publication
14.2.2019Translation submitted
15.4.2019Registration published
22.1.2027Expires
Owner
Name:
Regeneron Pharmaceuticals, Inc.Address:
777 Old Saw Mill River Road, 10591, Tarrytown, NY, US
Inventor
Name:
PAPADOPOULOS, Nicholas, J.Address:
Tarrytown, NY, US
Name:
MURPHY, Andrew, J.Address:
Tarrytown, NY, US
Name:
THURSTON, GavinAddress:
Tarrytown, NY, US
Name:
IOFFE, EllaAddress:
Tarrytown, NY, US
Name:
BUROVA, ElenaAddress:
Tarrytown, NY, US
Agent
Name:
Tego ehf.Address:
Pósthólf 8129, 128, Reykjavík,
Priority
Number:
201461930582 PDate:
23.1.2014Country:
US
Number:
201462089549 PDate:
9.12.2014Country:
US
Classification
Categories:
C07K 16/28, C07K 16/30, A61K 39/395, C07K 16/22, A61P 35/00, A61K 39/00, A61K 45/06
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 25.2.2019
Expires: 22.1.2020
Payer: PATICE, Ólafur Ragnarsson, hrl.
Number: 6
Paid: 18.12.2019
Expires: 22.1.2021
Payer: Ólafur Ragnarsson hrl.
Number: 7
Paid: 17.12.2020
Expires: 22.1.2022
Payer: Patice ehf.
Number: 8
Paid: 15.12.2021
Expires: 22.1.2023
Payer: Patice ehf.
Number: 9
Paid: 22.12.2022
Expires: 22.1.2024
Payer: Árnason Faktor ehf.
Number: 10
Paid: 20.12.2023
Expires: 22.1.2025
Payer: Árnason Faktor ehf.
Number: 11
Paid: 8.1.2025
Expires: 22.1.2026
Payer: Árnason Faktor ehf.
Number: 12
Paid: 12.1.2026
Expires: 22.1.2027
Payer: Árnason Faktor ehf.